Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2014

Feb 13, 2014

33625_dirs_2014-02-12_0783b69b-84f0-477e-a9f6-efe8aca0746e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2014-02-12

Reporting Person: Cooper Stephen E. (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A Preferred Stock $0.00 Common Stock (48333) Indirect
Series B Preferred Stock $0.00 Common Stock (19997) Indirect
Series C Preferred Stock $0.00 Common Stock (5125) Indirect
Series D Preferred Stock $0.00 Common Stock (18484) Indirect
Series C Preferred Stock $0.00 Common Stock (13564) Indirect
Series D Preferred Stock $0.00 Common Stock (333) Indirect
Series E Preferred Stock $0.00 Common Stock (833) Indirect

Footnotes

F1: Each share of (i) Series A Preferred Stock will automatically convert into 1.017087063 shares of the Issuer's Common stock, (ii) Series B Preferred Stock will automatically convert into 1.451080982 shares of the Issuer's Common Stock, (iii) Series C Preferred Stock will automatically convert into 1.730144671 shares of the Issuer's Common Stock, (iv) Series D Preferred Stock will automatically convert into 1.879505664 shares of the Issuer's Common Stock, and (v) Series E Preferred Stock will automatically convert into 2.692436975 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.

F2: Shares held by Stephen E. Cooper and Susan D. Cooper, as trustees of the Cooper Revocable Trust dated July 26, 1996.

F3: Shares held by the Stephen E. Cooper Family Partnership in which the reporting person is the General Partner and has voting and dispositive power over such shares.